​Can COVID Pills from Pfizer and Merck End the Pandemic? Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. × Search search POPULAR SEARCHES SUGGESTED LINKS Join AARP for just $9 per year when you sign up for a 5-year term. Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. Leaving AARP.org Website You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

Can COVID Pills End the Pandemic

Oral antivirals could hit the market soon Here s what that means for the course of COVID

dowell / Getty Images The U.S. may soon have access to two new antiviral pills that are designed to prevent hospitalization and death from in people who are most at risk for developing a serious case of the disease. If authorized, the first-of-their-kind treatments, from drugmakers Merck and Pfizer , could help to curtail the roughly 1,000 daily U.S. deaths still being caused by a coronavirus infection, though experts stress that remain the most important tool in the fight against COVID. Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. Unlike current COVID-19 treatments that are administered in health care facilities by injection or an IV, these oral antivirals can be dispensed at pharmacies and taken at home, making them more accessible and convenient for patients and health care providers. by the U.S. Food and Drug Administration (FDA) shows that molnupiravir, the pill from Merck and its partner Ridgeback Biotherapeutics, reduced the risk of hospitalization and death in high-risk patients by about 30 percent in clinical trials. Pfizer’s pill, whose brand name is Paxlovid, was shown in trials to cut risk by nearly 90 percent, . “It's another tool to add for those people who are at high risk for having hospitalization and death due to COVID-19, and I think it's a really important tool for them,” says Jason Pogue, a clinical professor of pharmacy at the University of Michigan College of Pharmacy and an infectious diseases clinical pharmacist at Michigan Medicine. “But there are some caveats that are going to come with that.” AARP Membership — $12 for your first year when you sign up for Automatic Renewal Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. to confirm a case of COVID-19. “And I continue to think that in this country we continue to have a problem with people having access to ready testing that's convenient and cheap and accurate . So that's going to be, I think, a real hurdle that we have to clear in order to use these drugs most effectively,” Rupp says. AARP Membership — $12 for your first year when you sign up for Automatic Renewal Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. . However, these tend to come with out-of-pocket expenses and may not be sensitive enough to pick up an infection early in the disease course , when the drugs are most effective.

Pills are not a replacement for prevention

For those who have compromised immune systems or other risk factors that make them more likely to get seriously ill from a coronavirus infection, these new oral treatments could be “a game changer ,” by helping to keep them out of the hospital, David Dowdy, M.D., associate professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, said in a recent media briefing. But they “are not going to be a game changer for prevention, the way the vaccines are,” he added. Entertainment $3 off popcorn and soft drink combos See more Entertainment offers > Treatments, pill or otherwise, also don’t help thwart transmission of the virus, which continues to spread at high levels throughout most of the U.S. Its continued spread also enables it to morph into new and potentially more dangerous variants , as evidenced by the rapid and worrisome emergence of the in South Africa. What’s more, experts are still reviewing the safety data for the pills, and it may be that some populations are excluded from their use. Even if the FDA OKs the new treatments and adds them to the COVID arsenal, we’re still “a long ways” from being done with the pandemic, Rupp adds. And older adults, in particular, need to continue to maintain a level of caution while the battle continues.

Need help getting a COVID-19 vaccine or booster

Visit or call 1-800-232-0233 (TTY: 888-720-7489) for assistance in English, Spanish, and many other languages. His advice: If you start to experience any , even if you are vaccinated, talk to your health care provider. “Don't delay. Go ahead and get tested and get put on medicine that will hopefully prevent that breakthrough case from becoming more severe and landing you in the hospital,” he says. Also, get vaccinated if you haven’t already , to help prevent the need for treatment in the first place. “The thing that would change the trajectory of the entire pandemic would be increasing vaccination rates, which is something that we still are really struggling with in this country,” Pogue says. Rachel Nania writes about health care and health policy for AARP. Previously she was a reporter and editor for WTOP Radio in Washington, D.C. A recipient of a Gracie Award and a regional Edward R. Murrow Award, she also participated in a dementia fellowship with the National Press Foundation. More on health AARP Membership — $12 for your first year when you sign up for Automatic Renewal Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. AARP VALUE & MEMBER BENEFITS See more Health & Wellness offers > See more Flights & Vacation Packages offers > See more Finances offers > See more Health & Wellness offers > SAVE MONEY WITH THESE LIMITED-TIME OFFERS